Objective Under the leadership of the major Europe-based vaccine industry players, IPROVE (Innovation Partnership for a Roadmap on Vaccines in Europe) will produce a comprehensive roadmap on the future of vaccine R&D, production and delivery in the EU. IPROVE aims to drive current EU research efforts towards the establishment of a clear vision of the priority innovations and technologies necessary to address infectious and non-infectious threats of importance not only to global public health, but also to today’s key EU health challenges (e.g. ageing population, healthcare-associated infections, high chronic disease incidence, low levels of prevention awareness, and suboptimal use of existing cost-effective vaccines across the lifespan). The roadmap will explore how the wealth of expertise available across academia, industry, SMEs, public health institutes, and regulatory bodies can be pooled and leveraged to overcome fragmentation and removal of bottlenecks to the timely translation of breakthrough research into innovative vaccines. The project will look at the entire innovation chain, from discovery to delivery, including interventions necessary to improve education curricula, perception and awareness. IPROVE proposes to achieve its goal using a consultation-based stakeholder collaborative process bringing together the key public and private players in the vaccine field in Europe and beyond. This will contribute to understanding the scientific, political and economic potential to be tapped in order to favour a more structured vaccine innovation agenda. The roadmap is expected to inform strategic decisions on the priorities for future vaccine investment at EU and MS level. The exercise is considered key to secure that the EU is capable of tackling changing medical needs and strained healthcare system budgets. Strengthening the EU’s vaccine research base will also protect and grow the EU’s economic competitiveness in this area, where Europe has traditionally maintained a position of leadership. Fields of science medical and health scienceshealth sciencespublic healthmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines Programme(s) FP7-HEALTH - Specific Programme "Cooperation": Health Topic(s) HEALTH.2013.4.1-4 - Preparing the future for health research and innovation Call for proposal FP7-HEALTH-2013-INNOVATION-1 See other projects for this call Funding Scheme CSA-SA - Support actions Coordinator FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES EU contribution € 153 440,00 Address Rue du trone 108/1 1050 Bruxelles / brussel Belgium See on map Region Région de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest Région de Bruxelles-Capitale/ Brussels Hoofdstedelijk Gewest Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad Activity type Other Administrative Contact Karam Adel Ali (Mr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data Participants (4) Sort alphabetically Sort by EU Contribution Expand all Collapse all EUROPEAN VACCINE INITIATIVE EWIV Germany EU contribution € 78 067,00 Address Vossstrasse 2 geb 4040 69115 Heidelberg See on map Region Baden-Württemberg Karlsruhe Heidelberg, Stadtkreis Activity type Research Organisations Administrative Contact Odile Leroy (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data SCLAVO VACCINES ASSOCIATION Italy EU contribution € 182 500,00 Address Piazza la lizza 7 53100 Siena See on map Region Centro (IT) Toscana Siena Activity type Research Organisations Administrative Contact Donata Medaglini (Prof.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data STICHTING EATRIS Participation ended Netherlands EU contribution € 351,92 Address Laan van nieuw oost indie 334 2593 CE Den haag See on map Activity type Research Organisations Administrative Contact Giovanni Migliaccio (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data EATRIS ERIC Netherlands EU contribution € 82 008,08 Address De boelelaan 1118 1081 HZ Amsterdam See on map Region West-Nederland Noord-Holland Groot-Amsterdam Activity type Research Organisations Administrative Contact Anne-Charlotte Fauvel (Ms.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data